Immunization News and Research

RSS

COVID-19 vaccination coverage and breakthrough infections in urban slums of India

A new study aimed to identify COVID-19 vaccination coverage, examine the factors responsible for COVID-19 vaccination coverage and vaccine hesitancy, study adverse events following immunization patterns after COVID-19 vaccination and determine the prevalence of breakthrough infection after COVID-19 vaccination.

30 Nov 2021

Interventions most effective in containing SARS-CoV-2 spread

A new study finds that viral transmission cannot be contained effectively using individual interventions at realistic levels of compliance.

29 Nov 2021

COVID vaccines effectively reduce outbreaks of SARS-CoV-2 alpha and delta viruses in households

A team of UK-based scientists has recently evaluated the effectiveness of coronavirus disease 2019 (COVID-19) vaccines in preventing household transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in England.

28 Nov 2021

An analysis of SARS-CoV-2 breakthrough infections by variant and vaccine

Researchers compared the distribution of SARS-CoV-2 genotypes to the prevalence of SARS-CoV-2 variants.

28 Nov 2021

Low neutralizing antibody titers against SARS-CoV-2 Mu in BNT162b2 vaccinated

Researchers assess the neutralizing antibody titers in BNT162b2-vaccinated people against SARS-CoV-2 isolates from the Mu, Gamma, and B.1.111 lineages.

28 Nov 2021

Using dried blood spots to monitor SARS-CoV-2 antibodies at home

The Roche Elecsys® anti-SARS-CoV-2 S immunoassay was used to demonstrate its ability to measure SARS-CoV-2 antibodies from DBS samples.

28 Nov 2021

Vaccination provides full protection against severe outcomes of COVID-19 among U.S. Coast Guard

Researchers performed a time-series analysis to evaluate the effectiveness of COVID-19 vaccination in the U.S. CG against SARS-CoV-2 infection.

28 Nov 2021

Efficacy and safety of an RBD-based recombinant protein COVID-19 vaccine

A study developed a protein-based subunit vaccine, PHH-1V, that consisted of a recombinant RBD fusion heterodimer of the alpha) and beta variants of SARS-CoV-2.

26 Nov 2021

SARS-CoV-2 vaccine based on vesicular stomatitis virus exhibits high neutralizing efficacy against variants

Scientists have tested the efficacy of BriLife®-vaccinated human sera in neutralizing more infectious and probably more virulent SARS-CoV-2 variants.

26 Nov 2021

Study compares immune responses of patients with and without kidney failure after COVID-19 vaccination

Death rates from COVID-19 are especially high in individuals with kidney failure who are on dialysis, making SARS-CoV-2 vaccination in this population a high priority.

24 Nov 2021

Births and deaths need to be accurately registered in Asia Pacific countries

A strong, universal, responsive civil registration and vital statistics (CRVS) system is critical for Asia Pacific countries to recover from the COVID-19 pandemic and ensure that the most vulnerable have access to healthcare, immunization and social welfare services.

24 Nov 2021

Antibody persistence in infants after maternal COVID-19 vaccination

New research finds COVID-19 vaccination during pregnancy results in significantly greater antibody persistence in the infants compared to natural infection of the mothers during pregnancy.

24 Nov 2021

Limited immune responses three months after Pfizer-BioNTech vaccination among elderly

In this study, published on the medRxiv* preprint server, the humoral response to SARS-CoV-2 was assessed before and after three months of administration of the BNT162b2 mRNA COVID-19 vaccination (Pfizer-BioNTech). In addition, elders' humoral responses were compared to those of a younger group, and a functional neutralization experiment against the Wuhan-Hu-1 (WH1) virus and the Delta variant was carried out.

23 Nov 2021

Vaccine-induced immune responses for SARS-CoV-2 in patients receiving anti-CD20 B-cell depleting therapies

A new study published on the medRxiv* preprint server analyzed the trajectories of anti-SARS-CoV-2 antibodies in patients from the RituxiVac study were compared to healthy volunteers. In addition, they investigated the immunogenicity of a third vaccine dose in previously non-responding patients.

23 Nov 2021

Immunization News and Research

COVID-19 vaccination coverage and breakthrough infections in urban slums of India

Interventions most effective in containing SARS-CoV-2 spread

COVID vaccines effectively reduce outbreaks of SARS-CoV-2 alpha and delta viruses in households

An analysis of SARS-CoV-2 breakthrough infections by variant and vaccine

Low neutralizing antibody titers against SARS-CoV-2 Mu in BNT162b2 vaccinated

Using dried blood spots to monitor SARS-CoV-2 antibodies at home

Vaccination provides full protection against severe outcomes of COVID-19 among U.S. Coast Guard

Efficacy and safety of an RBD-based recombinant protein COVID-19 vaccine

SARS-CoV-2 vaccine based on vesicular stomatitis virus exhibits high neutralizing efficacy against variants

Study compares immune responses of patients with and without kidney failure after COVID-19 vaccination

Births and deaths need to be accurately registered in Asia Pacific countries

Antibody persistence in infants after maternal COVID-19 vaccination

Limited immune responses three months after Pfizer-BioNTech vaccination among elderly

Vaccine-induced immune responses for SARS-CoV-2 in patients receiving anti-CD20 B-cell depleting therapies

Study shows risk of MIS-C post mRNA vaccination against COVID-19 in children with autoimmune complications

LSHTM joins with YouTube and Klick Health to create 'Community Unity' for tackling vaccine misinformation

Antigenic cocktail produced in Nicotiana benthamian plant as a potential COVID-19 vaccine candidate

Tobacco mosaic virus nanoparticle-based novel COVID-19 vaccine candidate

Inactivated virion-based vaccine confers robust cell-mediated immunity against major SARS-CoV-2 variants

Systematic review finds COVID-19 vaccine efficacy remains high for at least six months

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News